We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
MICAL1
  • TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

MICAL1

Gene description

Microtubule associated monooxygenase, calponin and LIM domain containing 1

Protein class

Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

5
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Cell line enhanced (THP-1)
HPA (normal tissue):Mixed

Protein evidence

Evidence at protein level

Protein expression
normal tissue

General cytoplasmic expression.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data.

Reliability score

Approved based on 3 antibodies.
HPA030175 , HPA030176 , HPA030178
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in pancreatic cancer (favourable) and renal cancer (unfavourable).
Pancreatic cancer p<0.001
Renal cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA030175
HPA030176
HPA030178

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

A majority of gliomas, basal cell carcinomas and colorectal cancers displayed moderate cytoplasmic positivity. Additional membranous staining was observed in a few stomach and colorectal cancers. Remaining cancers were in general weakly stained or negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancers displayed weak to moderate cytoplasmic staining combined with membranous positivity in several cases. Most lymphomas and seminomas along with cases of melanomas, urothelial, ovarian, prostate and colorectal cancers were strongly positive. Most gliomas, renal, urothelial and liver cancers were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Few cases of seminomas in testis showed moderate cytoplasmic positivity. Remaining cancers were generally negative.

GENE INFORMATION

Gene name

MICAL1 (HGNC Symbol)

Synonyms

DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL

Description

Microtubule associated monooxygenase, calponin and LIM domain containing 1 (HGNC Symbol)

Entrez gene summary

This gene encodes an enzyme that oxidizes methionine residues on actin, thereby promoting depolymerization of actin filaments. This protein interacts with and regulates signalling by NEDD9/CAS-L (neural precursor cell expressed, developmentally down-regulated 9). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]

Chromosome

6

Cytoband

q21

Chromosome location (bp)

109444062 - 109465968

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000135596 (version 83.38)

Entrez gene

64780

UniProt

Q8TDZ2 (UniProt - Evidence at protein level)

neXtProt

NX_Q8TDZ2

Antibodypedia

MICAL1 antibodies

PROTEIN BROWSER

MICAL1-001
MICAL1-002
MICAL1-006
MICAL1-007
MICAL1-008

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

MICAL1-001
ENSP00000351664
ENST00000358807
Q8TDZ2 [Direct mapping]
Protein-methionine sulfoxide oxidase MICAL1
Show all
   MEMSAT3 predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003779 [actin binding]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005882 [intermediate filament]
GO:0007010 [cytoskeleton organization]
GO:0007165 [signal transduction]
GO:0008270 [zinc ion binding]
GO:0016709 [oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen]
GO:0017124 [SH3 domain binding]
GO:0019417 [sulfur oxidation]
GO:0030042 [actin filament depolymerization]
GO:0055114 [oxidation-reduction process]
GO:0071949 [FAD binding]
Show all
1067 aa
117.9 kDa
No 0
MICAL1-002
ENSP00000408924
ENST00000433205
H0Y6Z4 [Direct mapping]
Protein-methionine sulfoxide oxidase MICAL1
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
Show all
252 aa
27.1 kDa
No 0
MICAL1-006
ENSP00000407075
ENST00000431946
Q5TED7 [Direct mapping]
Protein-methionine sulfoxide oxidase MICAL1
Show all
   MEMSAT3 predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0071949 [FAD binding]
Show all
244 aa
26.8 kDa
No 0
MICAL1-007
ENSP00000486901
ENST00000630715
Q8TDZ2 [Direct mapping]
Protein-methionine sulfoxide oxidase MICAL1
Show all
   MEMSAT3 predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001933 [negative regulation of protein phosphorylation]
GO:0003779 [actin binding]
GO:0004497 [monooxygenase activity]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005882 [intermediate filament]
GO:0007010 [cytoskeleton organization]
GO:0007165 [signal transduction]
GO:0008270 [zinc ion binding]
GO:0016709 [oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen]
GO:0017124 [SH3 domain binding]
GO:0017137 [Rab GTPase binding]
GO:0019417 [sulfur oxidation]
GO:0030042 [actin filament depolymerization]
GO:0043066 [negative regulation of apoptotic process]
GO:0043154 [negative regulation of cysteine-type endopeptidase activity involved in apoptotic process]
GO:0055114 [oxidation-reduction process]
GO:0071949 [FAD binding]
Show all
1086 aa
119.8 kDa
No 0
MICAL1-008
ENSP00000351385
ENST00000358577
Q8TDZ2 [Direct mapping]
Protein-methionine sulfoxide oxidase MICAL1
Show all
   MEMSAT3 predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003779 [actin binding]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005882 [intermediate filament]
GO:0007010 [cytoskeleton organization]
GO:0007165 [signal transduction]
GO:0008270 [zinc ion binding]
GO:0016709 [oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen]
GO:0017124 [SH3 domain binding]
GO:0019417 [sulfur oxidation]
GO:0030042 [actin filament depolymerization]
GO:0055114 [oxidation-reduction process]
GO:0071949 [FAD binding]
Show all
981 aa
108.6 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.